Yu Yong
Chief Scientific Officer
Yu Yong has filed 7 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Yu Yong is listed as Chief Scientific Officer at GENELUX Corp. Inside the rolling window, Yu Yong reported no open-market purchases and 6 open-market sales totaling $49K in GNLX. The largest disclosed transaction in the window is a sale of 9,683 GNLX shares on Aug 31, 2026, worth $27K.
Companies traded
Other insiders at GNLX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$49K
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| GNLX | Chief Scientific Officer | Sale | 9,683 | $27K | Sep 2 | SEC ↗ | |
| GNLX | Chief Scientific Officer | Sale | 653 | $2K | Aug 5 | SEC ↗ | |
| GNLX | Chief Scientific Officer | Sale | 605 | $2K | May 13 | SEC ↗ | |
| GNLX | SVP, Clinical Development | Sale | 906 | $2K | Mar 26 | SEC ↗ | |
| GNLX | SVP, Clinical Development | Sale | 3,219 | $11K | Dec 11 | SEC ↗ | |
| GNLX | SVP, Clinical Development | Sale | 973 | $5K | Dec 11 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Yu Yong made?
Yu Yong has filed 7 SEC Form 4 filings (20 transaction rows) across 1 company since 2025.
Which companies does Yu Yong trade?
Yu Yong has filed SEC Form 4 disclosures for 1 company, including GNLX.
When was Yu Yong's most recent SEC Form 4 filing?
Yu Yong's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Yu Yong's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Yu Yong is listed as Chief Scientific Officer.
What is Yu Yong's total buy and sell value in the current window?
Inside the rolling retention window, Yu Yong bought $0 and sold $49K based on SEC Form 4 filings.
What was Yu Yong's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,683 GNLX shares on 2026-08-31, worth $27K, per SEC Form 4 filings.